Published on 30/11/2025

Defending ‘Verification Only’ Calls: Evidence and Language

Introduction to Change Control and Validation Strategies

In the pharmaceutical industry, effective change control systems are essential for ensuring product quality, compliance, and safety. Change control encompasses the processes for managing and documenting changes in manufacturing processes, facilities, materials, and equipment. One area that often creates confusion is the distinction between verification and re-validation when changes occur. Regulatory bodies, such as the FDA, the EMA, and the MHRA, have specific guidelines that underscore the importance of thorough change assessments.

This tutorial will provide a detailed examination of defending ‘verification only’ calls, focusing on effective strategies for impact assessment related to packaging changes, bridging studies, and sampling plan updates. Understanding these elements is fundamental for professionals involved in quality assurance (QA), quality control (QC), and regulatory compliance.

Understanding Verification vs. Re-Validation

At the core of pharmaceutical validation is the understanding of the terms ‘verification’ and ‘re-validation.’ Verification typically refers to actions taken to confirm that the processes or systems remain within established limits, while re-validation is a more extensive procedure that entails re-evaluating the entire validation status of a system or process.

When analyzing change control decisions, particularly regarding packaging, one must evaluate the significance of the changes. For instance, a minor alteration in packaging materials may be classified under a ‘verification only’ call if it does not affect product sterility or integrity. In contrast, substantial shifts in formulation could necessitate a full re-validation.

Key Factors in Determining Verification Needs

• Nature of Change: Evaluate whether the change is minor or major.
• Regulatory Guidance: Refer to specific regulations such as Annex 15 and 21 CFR Part 211 for insights.
• Risk Assessment: Conduct a risk-based assessment to gauge potential impacts on product quality.
• Historical Data: Review historical performance to support the case for verification.

Determining whether a change can be classified under ‘verification only’ is not solely subjective; a structured approach leveraging data and aligned with risk-based change thresholds is essential.

Framework for Change Control Impact Assessment

The change control impact assessment framework is pivotal in justifying ‘verification only’ calls. The integration of risk management principles allows professionals to identify potential impacts effectively and determine mitigating actions. This framework should incorporate the following stages:

Step 1: Identification of Changes

• Document all proposed changes and classify them according to predefined categories.
• Include alterations to processes, equipment, raw materials, and packaging.

Step 2: Risk Assessment

Utilize risk identification tools, such as Failure Mode and Effects Analysis (FMEA). Calculate risk priority numbers (RPN) for each proposed change:

• Severity: Assess the impact on product quality.
• Occurrence: Estimate the likelihood of the failure occurring.
• Detection: Determine the ability to detect the failure before it reaches consumers.

Step 3: Decide on Verification vs. Re-Validation

After assessing risks, determine appropriate validation strategies:

• If the RPN is low, consider a verification approach with effectiveness checks.
• For medium or high RPNs, a comprehensive re-validation may be necessary.

Step 4: Implementation and Documentation

Actions decided in the previous steps should be meticulously documented, including:

• Reasons for selecting verification only.
• Rationale supporting the absence of need for re-validation.
• Details of any effectiveness checks or sampling plans implemented.

Bridging Studies: A Key Component in Change Control

Bridging studies are essential when changes involve significant differences that could impact the endpoint data during transitions from one version to another. They help bridge the knowledge gap from old to new systems or processes. Understanding the bridging concept is critical for executing a successful change control program.

Bridging studies typically focus on maintaining product quality during process changes. For packaging alterations, a well-defined bridging study is essential to prove that the new packaging does not detrimentally impact sterility margins or stability profiles.

Designing Effective Bridging Studies

• Define Objectives: Clearly state objectives to establish the rationale for changes.
• Establish Acceptance Criteria: Set standards to demonstrate that the new packaging aligns with historical performance metrics.
• Conduct Comparative Studies: Use comparative product testing, considering sampling plan updates to determine any variances in performance.

Data obtained should contribute significantly to justifying ‘verification only’ calls. It establishes a well-founded basis for the conclusion that the new packaging or process remains within acceptable parameters.

Preparing Effective Evidence Packs

Effective evidence packs are imperative for supporting change proposals and demonstrating compliance with regulatory expectations. An evidence pack should provide a comprehensive overview of the change and its implications for product quality and safety.

Components of an Evidence Pack

• Change Description: Detailed information on what is changing, why it is changing, and how it will be implemented.
• Supporting Data: Include risk assessments, impact analyses, historical performance data, and any conducted bridging studies.
• Regulatory References: Cite applicable regulations, guidelines, and best practices relevant to the change.

Tailoring Evidence Packs for Regulatory Review

When preparing evidence packs, it is crucial to tailor the content based on the audience:

• For internal stakeholders, focus on detailed operational impacts.
• For external reviewers, emphasize adherence to guidelines and regulatory compliance.

Effective presentation of the evidence pack is vital for successful communication and validation of the proposed verification only approach.

Periodic Review and Effectiveness Checks

To maintain compliance and product integrity over time, the processes of periodic review and effectiveness checks are imperative. These measures help to audit and assess the continued suitability of the verification only calls.

Implementing Periodic Reviews

Establish a systematic schedule for periodic reviews that aligns with changing conditions within processes or regulatory expectations. The reviews should encompass:

• Regular analyses of historical data to inspect long-term trends.
• Assessment of any incidents or deviations that occur related to the specific change in question.
• Updates in regulations or operational frameworks that could necessitate a new change control assessment.

Effectiveness Checks: Ongoing Verification

Effectiveness checks serve as a tool to ensure that the changes introduced through the verification process yield satisfactory outcomes. These checks should incorporate:

• Routine testing of product quality post-changes.
• Results from compliance audits that assess adherence to established thresholds.
• Feedback loops that adapt processes based on effectiveness data collected.

Conclusion: Building a Strong Defense for ‘Verification Only’ Calls

Defending ‘verification only’ calls requires a thorough understanding of regulatory expectations and the implementation of robust change control processes. By adopting a structured framework that incorporates risk assessment, bridging studies, and effective documentation, a strong rationale can be established for such calls.

Periodic review and effectiveness checks further reinforce the integrity of these calls, ensuring compliance with regulations from authoritative bodies like the PIC/S and others. In a highly regulated environment, maintaining clarity and rigor in change control processes is not just beneficial; it is essential for the ongoing success and safety of pharmaceutical products served to the market.